An exploratory analysis of bone scan lesion area (BSLA), circulating tumor cell (CTC) change, pain reduction, and overall survival (OS) in patients (pts) with castration-resistant prostate cancer (CRPC) treated with cabozantinib (cabo): Updated results of a phase II nonrandomized expansion (NRE) cohort Meeting Abstract

  

Authors:	Scher, H. I.; Smith, M. R.; Sweeney, C.; Corn, P. G.; Logothetis, C.; Vogelzang, N. J.; Smith, D. C.; Hussain, M.; George, D. J.; De Bono, J. S.; Higano, C. S.; Small, E. J.; Goldin, J.; Brown, M. S.; Aftab, D. T.; Noursalehi, M.; Weitzman, A.; Basch, E. M.
Abstract Title:	An exploratory analysis of bone scan lesion area (BSLA), circulating tumor cell (CTC) change, pain reduction, and overall survival (OS) in patients (pts) with castration-resistant prostate cancer (CRPC) treated with cabozantinib (cabo): Updated results of a phase II nonrandomized expansion (NRE) cohort
Meeting Title:	49th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title:	Journal of Clinical Oncology
Volume:	31
Issue:	15 Suppl.
Meeting Dates:	2013 May 31-Jun 4
Meeting Location:	Chicago, IL
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2013-05-20
Language:	English
ACCESSION:	WOS:000335419601626
PROVIDER:	wos
DOI:	10.1200/jco.2013.31.15_suppl.5026
Notes:	Meeting Abstract: 5026 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/128788